Boston Scientific Gross Carrying Amount increased by 0.8% to $17.58B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $16.18B to $17.58B. Over 4 years (FY 2020 to FY 2024), Gross Carrying Amount shows an upward trend with a 6.5% CAGR.
An increase suggests recent acquisitions or investments in software and intellectual property, while a decrease may indicate asset retirement or impairment.
This represents the total original acquisition cost of intangible assets with a defined useful life before accounting fo...
Common across capital-intensive industries; peers typically report this as part of total intangible assets.
other_finite_lived_intangible_assets_gross| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.61B | $14.14B | $14.35B | $14.99B | $14.96B | $14.80B | $14.84B | $15.19B | $15.46B | $15.45B | $15.82B | $15.86B | $15.51B | $16.18B | $17.19B | $17.29B | $17.45B | $17.58B |
| QoQ Change | — | +3.9% | +1.5% | +4.5% | -0.3% | -1.0% | +0.3% | +2.3% | +1.8% | -0.1% | +2.4% | +0.3% | -2.2% | +4.3% | +6.2% | +0.6% | +0.9% | +0.8% |
| YoY Change | — | — | — | — | +9.9% | +4.7% | +3.4% | +1.3% | +3.4% | +4.4% | +6.6% | +4.5% | +0.3% | +4.8% | +8.7% | +9.0% | +12.5% | +8.6% |